DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Cilostazol
Cilostazol
Health Reports for Mutual Recognition of Medical Prescriptions: State of Play
Cilostazol Protects Rats Against Alcohol‑Induced Hepatic Fibrosis Via Suppression of TGF‑Β1/CTGF Activation and the Camp/Epac1 Pathway
Wo 2010/075090 A2
PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
Cilostazol Tablets, USP50 Mg and 100 Mgrx Only
Guideline for Preoperative Medication Management
Pharmacokinetic Characteristics of Cilostazol 200 Mg Controlled
Use of Antiplatelet Therapies During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction
New Drugs: T-Score for Transparency
Platelet-Inhibiting Drugs: a Hematologist’S Perspective
Antithrombotic Therapy for Secondary Prevention in Patients with Non-Cardioembolic Stroke Or Transient Ischemic Attack: a Systematic Review
A Randomized, Controlled Trial Comparing Cilostazol with Extended Release Dipyridamole in the Management of Intermittent Claudication in Peripheral Artery Disease
Co-Loaded Curcumin and Methotrexate Nanocapsules Enhance Cytotoxicity Against Non-Small-Cell Lung Cancer Cells
Safety and Efficacy of Prasugrel with Endovascular Treatment for Unruptured Cerebral Aneurysm
Advances in Interventional Cardiology New Directions In
Guideline/Protocol Title: GUIDELINES for the USE of ANTITHROMBOTIC AGENTS in the SETTING of NEURAXIAL PROCEDURES
Evaluation of the Antiplatelet Effects of Cilostazol, a Phosphodiesterase 3 Inhibitor, by VASP Phosphorylation and Platelet Aggregation
Multitarget-Based Cotreatment with Cilostazol and Celecoxib Synergistically Suppresses Collagen-Induced Arthritis in Mice by Enhancing Interleukin-10 T Expression
Top View
Neuraxial Or Nerve Procedures
Management of Antiplatelet Therapy in Patients Undergoing Neuroendovascular Procedures
Platelet Aggregation Inhibitors
Pharmacogenomic Associations Tables
Phosphodiesterase Inhibitors in Acute Lung Injury: What Are the Perspectives?
Non-Dental Drugs a Dentist Should Know: a Review
Neutrophil Stunning by Metoprolol Reduces Infarct Size
Ameliorative Effect of Metformin on Methotrexate-Induced Genotoxicity: an in Vitro Study in Human Cultured Lymphocytes
Preventive Generics Drug List
Cilostazol Improves HFD-Induced Hepatic Steatosis by Upregulating
Theophylline As an Adjunct to Control Malignant Ventricular Arrhythmia
Cilostazol, a Phosphodiesterase Inhibitor, Prevents No-Reflow and Hemorrhage in Mice with Focal Cerebral Ischemia
(12) Patent Application Publication (10) Pub. No.: US 2013/0252924 A1 Penninger Et Al
(Therapeutic Products) Regulations 2015
Cilostazol, a Phosphodiesterase Inhibitor, Prevents No-Reflow and Hemorrhage in Mice with Focal Cerebral Ischemia
The Clinical Effects of Cilostazol on Atherosclerotic Vascular Disease
Randomized Comparison of Cilostazol Vs Ticlopidine for Antiplatelet Therapy After Coronary Stenting
Optimizing Oral Antiplatelet Therapy in Acute Coronary Syndrome
Package Leaflet
Cilostazol Art 31
Medicaid-Approved Preferred Drug List
Pharmacokinetic Herb-Drug Interactions (Part 2): Drug Interactions Involving Popular Botanical Dietary Supplements and Their Clinical Relevance
An in Vitro Investigation Into the Mechanism of the Clinically Relevant Drug-Drug Interaction Between Omeprazole Or Esomeprazole and Clopidogrel
PLETAL (Cilostazol) Tablets, for Oral Use
Antiplatelet Options: the Changing Landscape
NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
The Effect of Caffeine on Migraine Headaches
The Efficacy and Safety of Cilostazol As an Alternative to Aspirin in Chinese
Customs Tariff - Schedule Xxi - 1
Antiplatelet Therapies for the Treatment of Cardiovascular Disease
Insights from Experiences on Antiplatelet Drugs in Stroke Prevention: a Review
Effects on Uric Acid Metabolism of the Drugs Except the Antihyperuricemics
Platelet Aggregation Inhibitors (PDF)
Cilostazol) (Sil-OS-Tah-Zol) Tablets
Formulation of New Sildenafil Citrate-Caffeine Orally Disintegrating Tablets: in Vitro and in Vivo Evaluation
Cilostazol-Containing Medicinal Product (See Annex I) 50 Mg Tablets Cilostazol-Containing Medicinal Product (See Annex I) 100 Mg Tablets
Positive Chronotropic Effects of Theophylline and Cilostazol in Patients with Symptomatic Sick Sinus Syndrome Who Have Declined Permanent Pacing
Cangrelor Or Clopidogrel in Patients with Type 2 Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: a Meta-Analysis of Randomized Controlled Trials
Study Protocol and Any Subsequent Amendments
01 Stockley's Herbal Medicines Interactions PRELIMS 1
P2Y12 Antiplatelet Choice for Patients with Chronic Kidney Disease and Acute Coronary Syndrome: a Systematic Review and Meta-Analysis
Your 2021 Formulary
Hypoglycemia During the Concomitant Use of Repaglinide and Clopidogrel in an Elderly Patient with Type 2 Diabetes and Severe Renal Insufficiency
Pharmaceutical Appendix to the Tariff Schedule 2
Drug Interactions with Herbal Medicines
A Pilot Study of Cilostazol to Improve Quality-Of-Life and Long Term Patency After Open Or Endovascular Revascularization for Peripheral Artery Disease
A Prospective Randomized Multi-Center Study of Antiplatelet Using Cilostazol Versus Ticlopidine Undergoing Coronary Artery Stenting
(19) United States (12) Patent Application Publication (10) Pub
HIGHLIGHTS of PRESCRIBING INFORMATION These Highlights Do Not Include All the Information Needed to Use PLETAL Safely and Effect
Effects of Phosphodiesterase Inhibitors on Secretions of Human Monokines
A New Pharmacological Treatment for Intermittent Claudication:Results Of
Clinical Practice Guideline
Efficacy of Cilostazol on Platelet Reactivity and Cardiovascular
Antiplatelet Drugs: a Review of Their Pharmacology and Management in the Perioperative Period
A Systematic Review and Economic Evaluation of Cilostazol, Naftidrofuryl
Cilostazol Is Useful for the Treatment of Sinus Bradycardia And
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Blood Brain Barrier Dysfunction in Chronic Cerebral Ischemia
Adjunctive Cilostazol to Dual Antiplatelet Therapy to Enhance
Cilostazol (Pletal) – Would Need to Be Stopped Two to Three Days Prior to Surgery
Audio) • Unceasing Customer Service
Comparison of Prasugrel and Clopidogrel in Patients with Non-Cardioembolic Ischaemic Stroke: a Phase 3, Randomised, Non-Inferiority Trial (PRASTRO-I)
Effective 07-01-2021) the Florida Medicaid Preferred Drug List (PDL